Evidence map›Paper›PMID 27904706›Full record

ArticleAmerican journal of translational research2016

The central role of HOTAIR in the malignancy of CD44+ human hypopharyngeal carcinoma cells.

Hongxia Cheng, Xinhua Cui, Ying Guo, Lintao Gu, Yaning Wang, Qirong Wang, Hui Liang

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hongxia ChengDepartment of Pathology, Provincial Hospital Affiliated to Shandong University 324, Jing 5 Rd, Jinan 250021, Shandong, China.
Xinhua CuiDepartment of Otolaryngology, Shandong Provincial Qianfoshan Hospital 16766, Jingshi Road, Jinan 250014, Shandong, China.
Ying GuoDepartment of Otolaryngology, Shandong Provincial Qianfoshan Hospital 16766, Jingshi Road, Jinan 250014, Shandong, China.
Lintao GuDepartment of Otolaryngology, Shandong Provincial Qianfoshan Hospital 16766, Jingshi Road, Jinan 250014, Shandong, China.
Yaning WangDepartment of Otolaryngology, Shandong Provincial Qianfoshan Hospital 16766, Jingshi Road, Jinan 250014, Shandong, China.
Qirong WangDepartment of Otolaryngology, Shandong Provincial Qianfoshan Hospital 16766, Jingshi Road, Jinan 250014, Shandong, China.
Hui LiangDepartment of Otolaryngology, Shandong Provincial Qianfoshan Hospital 16766, Jingshi Road, Jinan 250014, Shandong, China.
Shandong Provincial QianFoShan Hospital · CNShandong Provincial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human hypopharyngeal carcinoma is one of the most common malignant tumors. CD44 could serve as a molecular marker to screen for cancer stem cells (CSCs) in hypopharyngeal cancer. The aim of this study was to identify the role of HOX transcript antisense RNA (HOTAIR) on cell proliferation and invasion in CD44+ FADU cells (human hypopharyngeal carcinoma cells). We also explored the underlying mechanism contributing to HOTAIR's observed effects. CD44+ FADU cells were sorted and purified by flow cytometry and infected with lentivirus stably expressing HOTAIR shRNA. Cell proliferation and invasion analyses were carried out with cell counting kit-8 (CCK-8) and Transwell assays. The expressions of downstream effectors of HOTAIR, including E-cadherin, β-catenin, and vimentin were measured by quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting. Knockdown of HOTAIR markedly inhibited the proliferation and invasion of CD44+ FADU cells

Indexed as

cancer stem cellHOTAIRHuman hypopharyngeal carcinoma

Identifiers

PMID27904706
PMCPMC5126348
OpenAlexW2560745737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.